Patents by Inventor Aviv Shaish
Aviv Shaish has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20220175860Abstract: The present invention provides neuroprotective preparations, specifically, Dunaliella alga preparations and uses thereof in the treatment and prophylaxis of neurodegenerative disorders, protein misfolding and cognitive decline.Type: ApplicationFiled: April 1, 2020Publication date: June 9, 2022Inventors: Aviv SHAISH, Dror HARATS, Michal BEERI, Irit LUBITZ
-
Publication number: 20160279202Abstract: The invention provides IL-1 inhibitors, methods and uses thereof for retaining ovarian follicle reserve in a mammalian subject, treating infertility and improving responsiveness and sensitivity to COH. The invention further provides methods for improving oocyte quality and/or survival, specifically for IVF, and kits for combining COH treatment with the sensitizing IL-inhibitors of the invention.Type: ApplicationFiled: October 30, 2014Publication date: September 29, 2016Applicants: RAMOT AT TEL-AVIV UNIVERSITY LTD., TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND S ERVICES LTD.Inventors: Yehuda KAMARI, Ruth SHALGI, Shiri URI, Dror HARATS, Aviv SHAISH
-
Patent number: 9180152Abstract: The invention is a method for treating psoriasis in a subject suffering from psoriasis. The method includes orally administering to the subject a pharmaceutically-effective amount of crude Dunaliella powder.Type: GrantFiled: December 5, 2010Date of Patent: November 10, 2015Assignees: NIKKEN SOHONSHA CORPORATION, TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD.Inventors: Aviv Shaish, Dror Harats, Shoshana Greenberger
-
Patent number: 8961993Abstract: Provided is a method for improving day photopic vision and/or cone-derived visual field and visual function in a subject suffering from a retinal disease or trauma including administering to the subject a pharmaceutically effective amount of crude Dunaliella powder. Also provided is a method for improving night vision and/or rod derived visual field in a subject suffering from a retinal disease including administering to the subject a pharmaceutically effective amount of crude Dunaliella powder. A pharmaceutical composition for improving day vision and/or visual field in a subject suffering from a retinal disease including crude Dunaliella powder is also provided.Type: GrantFiled: July 18, 2013Date of Patent: February 24, 2015Assignees: Nikken Sohonsha Corporation, Tel Hashomer Medical Research Infrastructure and Services Ltd.Inventors: Michael Belkin, Aviv Shaish, Dror Harats, Ygal Rotenstreich
-
Publication number: 20140023702Abstract: Provided is a method for improving day photopic vision and/or cone-derived visual field and visual function in a subject suffering from a retinal disease or trauma including administering to the subject a pharmaceutically effective amount of crude Dunaliella powder. Also provided is a method for improving night vision and/or rod derived visual field in a subject suffering from a retinal disease including administering to the subject a pharmaceutically effective amount of crude Dunaliella powder. A pharmaceutical composition for improving day vision and/or visual field in a subject suffering from a retinal disease including crude Dunaliella powder is also provided.Type: ApplicationFiled: July 18, 2013Publication date: January 23, 2014Applicants: TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD., NIKKEN SOHONSHA CORPORATIONInventors: Michael BELKIN, Aviv SHAISH, Dror HARATS, Ygal ROTENSTREICH
-
Patent number: 8529907Abstract: Provided is a method for improving day photopic vision and/or cone-derived visual field and visual function in a subject suffering from a retinal disease or trauma including administering to the subject a pharmaceutically effective amount of crude Dunaliella powder. Also provided is a method for improving night vision and/or rod derived visual field in a subject suffering from a retinal disease including administering to the subject a pharmaceutically effective amount of crude Dunaliella powder. A pharmaceutical composition for improving day vision and/or visual field in a subject suffering from a retinal disease including crude Dunaliella powder is also provided.Type: GrantFiled: April 27, 2009Date of Patent: September 10, 2013Assignees: Nikken Sohonsha Corporation, Tel Hashomer Medical Research Infrastructure and Services Ltd.Inventors: Michael Belkin, Aviv Shaish, Dror Harats, Ygal Rotenstreich
-
Patent number: 8343549Abstract: A method for treating a disease selected from diabetes mellitus and atherosclerosis, and a method for reducing triglycerides and/or increasing HDL cholesterol levels in the plasma of a subject. The method comprises administrating to a subject an effective amount of crude Dunaliella powder, optionally together with an activator of nuclear receptors.Type: GrantFiled: May 11, 2010Date of Patent: January 1, 2013Assignees: Nikken Sohonsha Corporation, Tel Hashomer Medical Research Infrastructure and Services Ltd.Inventors: Aviv Shaish, Dror Harats
-
Publication number: 20120237597Abstract: A method for treating psoriasis in a subject suffering from psoriasis comprising orally administering to the subject a pharmaceutically effective amount of crude Dunaliella powder.Type: ApplicationFiled: December 5, 2010Publication date: September 20, 2012Applicant: NIKKEN SOHANSHA CORPORATIONInventors: Aviv Shaish, Dror Harats, Shoshana Greenberger
-
Publication number: 20110045035Abstract: Provided is a method for improving day photopic vision and/or cone-derived visual field and visual function in a subject suffering from a retinal disease or trauma including administering to the subject a pharmaceutically effective amount of crude Dunaliella powder. Also provided is a method for improving night vision and/or rod derived visual field in a subject suffering from a retinal disease including administering to the subject a pharmaceutically effective amount of crude Dunaliella powder. A pharmaceutical composition for improving day vision and/or visual field in a subject suffering from a retinal disease including crude Dunaliella powder is also provided.Type: ApplicationFiled: April 27, 2009Publication date: February 24, 2011Applicants: NIKKEN SOHONSHA CORPORATION, TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SEVICES LTD.Inventors: Michael Belkin, Aviv Shaish, Dror Harats, Ygal Rotenstreich
-
Publication number: 20100221348Abstract: A method for treating a disease selected from diabetes mellitus and atherosclerosis, and a method for reducing triglycerides and/or increasing HDL cholesterol levels in the plasma of a subject. The method comprises administrating to a subject an effective amount of crude Dunaliella powder, optionally together with an activator of nuclear receptors.Type: ApplicationFiled: May 11, 2010Publication date: September 2, 2010Applicants: NIKKEN SOHONSHA CORPORATION, TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD.Inventors: Aviv SHAISH, Dror HARATS
-
Patent number: 7763255Abstract: A method for treating a disease selected from diabetes mellitus and atherosclerosis, and a method for reducing triglycerides and/or increasing HDL cholesterol levels in the plasma of a subject. The method comprises administrating to a subject an effective amount of crude Dunaliella powder, optionally together with an activator of nuclear receptors.Type: GrantFiled: July 10, 2007Date of Patent: July 27, 2010Assignees: Nikken Sohonsha Corporation, Tel Hashomer Medical Research Infrastructure and Services Ltd.Inventors: Aviv Shaish, Dror Harats
-
Patent number: 7482032Abstract: A preparation comprising the carotenoids phytoene and phytofluene in an amount which, in combination, is effective in preventing various kinds of damage resulting from oxidation and exposure to UV light is provided. The preparation is essentially colorless and may be used as a topical cosmetic or pharmaceutical preparation as well as an additive in food preparations. In addition, a method for producing substantive amounts of phytoene and phytofluene from carotenoid producing organisms is described as well.Type: GrantFiled: March 14, 2002Date of Patent: January 27, 2009Assignee: I.B.R. Israeli Biotechnology Research, Ltd.Inventors: Etienne Soudant, Lea Bezalel, Hedva Schickler, Judith Paltiel, Ami Ben-Amotz, Aviv Shaish, Inon Perry
-
Publication number: 20080019997Abstract: A method for treating a disease selected from diabetes mellitus and atherosclerosis, and a method for reducing triglycerides and/or increasing HDL cholesterol levels in the plasma of a subject. The method comprises administrating to a subject an effective amount of crude Dunaliella powder, optionally together with an activator of nuclear receptors.Type: ApplicationFiled: July 10, 2007Publication date: January 24, 2008Applicants: NIKKEN SOHONSHA CORPORATION, TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD.Inventors: Aviv Shaish, Dror Harats
-
Patent number: 7264813Abstract: A method for treating a disease selected from diabetes mellitus and atherosclerosis, and a method for reducing triglycerides and/or increasing HDL cholesterol levels in the plasma of a subject. The method comprises administrating. to a subject an effective amount of crude Dunaliella powder, optionally together with an activator of nuclear receptors.Type: GrantFiled: September 24, 2003Date of Patent: September 4, 2007Assignees: Nikken Sohonsha Corporation, Tel Hashomer Medical Research Infrastructure and Services Ltd.Inventors: Aviv Shaish, Dror Harats
-
Publication number: 20050063991Abstract: A method for treating a disease selected from diabetes mellitus and atherosclerosis, and a method for reducing triglycerides and/or increasing HDL cholesterol levels in the plasma of a subject. The method comprises administrating. to a subject an effective amount of crude Dunaliella powder, optionally together with an activator of nuclear receptors.Type: ApplicationFiled: September 24, 2003Publication date: March 24, 2005Inventors: Aviv Shaish, Dror Harats
-
Publication number: 20020131940Abstract: A preparation comprising the carotenoids phytoene and phytofluene in an amount which, in combination, is effective in preventing various kinds of damage resulting from oxidation and exposure to UV light is provided. The preparation is essentially colorless and may be used as a topical cosmetic or pharmaceutical preparation as well as an additive in food preparations. In addition, a method for producing substantive amounts of phytoene and phytofluene from carotenoid producing organisms is described as well.Type: ApplicationFiled: March 14, 2002Publication date: September 19, 2002Applicant: I.B.R. ISRAELI BIOTECHNOLOGY RESEARCH, LTD.Inventors: Etienne Soudant, Lea Bezalel, Hedva Schickler, Judith Paltiel, Ami Ben-Amotz, Aviv Shaish, Inon Perry
-
Patent number: 6383474Abstract: A preparation comprising the carotenoids phytoene and phytofluene in an amount which, in combination, is effective in preventing various kinds of damage resulting from oxidation and exposure to UV light is provided. The preparation is essentially colorless and may be used as a topical cosmetic or pharmaceutical preparation as well as an additive in food preparations. In addition, a method for producing substantive amounts of phytoene and phytofluene from carotenoid producing organisms is described as well.Type: GrantFiled: May 18, 2001Date of Patent: May 7, 2002Assignee: I.B.R. Israeli Biotechnology Research, Ltd.Inventors: Etienne Soudant, Lea Bezalel, Hedva Schickler, Judith Paltiel, Ami Ben-Amotz, Aviv Shaish, Inon Perry